| abstract |
A vaccine composition useful for inducing immunoprotection in a host against rheumatoid arthritis hospital related arthritic peptides has been published. Each vaccine composition provides an antigenic dnaJp1 peptide (optionally comprising a polynucleotide encoding a peptide or peptide) and, optionally, a microbial dnaJ protein and / or a peptide fragment of a human homologue. Methods of identifying a person scheduled for the onset of rheumatoid arthritis and using the inventive vaccine have also been published.n n n n n n n n . |